Tru Independence Asset Management 2’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,454
Closed -$1.7M 77
2022
Q1
$1.7M Buy
3,454
+240
+7% +$110K 0.97% 21
2021
Q4
$1.49M Buy
3,214
+1,391
+76% +$585K 0.79% 27
2021
Q3
$680K Buy
1,823
+155
+9% +$58.9K 0.48% 44
2021
Q2
$637K Buy
1,668
+32
+2% +$12.2K 0.43% 51
2021
Q1
$587K Buy
1,636
+163
+11% +$52.4K 0.46% 56
2020
Q4
$473K Buy
+1,473
New +$452K 0.4% 60

Other funds holding ELV

Tru Independence Asset Management 2's ELV Position: Q2 2022 in Review

Tru Independence Asset Management 2 sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 3,454 shares — an estimated $1.7M sold.

Tru Independence Asset Management 2 first reported a position in ELV in Q4 2020 and held it in 6 quarters. The position peaked at $1.7M in Q1 2022. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Tru Independence Asset Management 2 reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Tru Independence Asset Management 2 sold 3,454 Elevance Health shares in Q2 2022, an estimated $1.7M.
  • Tru Independence Asset Management 2 first reported a position in Elevance Health in Q4 2020 and held it in 6 quarters.
  • Tru Independence Asset Management 2's Elevance Health position peaked at $1.7M in Q1 2022.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Tru Independence Asset Management 2's 13F filing for Q2 2022, filed 2 Aug 2022.